Catalent
Catalent
Catalent’s Bold Move: New HQ in Tampa!
🌟 Catalent has officially opened its new global headquarters in Tampa, enhancing operations and service capabilities in Florida! 🏢✨
Gene Therapy Breakthrough Acquisition and Bankruptcy Shake Biotech Industry!
📰 Intellia and Ultragenyx's clinical updates, Novo Holdings' Catalent acquisition, and NanoString bankruptcy; Simon Barnett 💊💼💥💡
Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼
Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.
Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth
🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈
Catalent’s Game-Changing CAR-T Platform Revolutionizes Immunocellular Therapy
🚀 Catalent launches a plug-and-play CAR-T platform 🛠️ designed to streamline development and manufacturing of immunocellular therapies. 🌟🔬💼
